Overview
Location
United States
Total raised
$47.8M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 14, 2026 | BlueWind Medical: $47.8 Million Funding Raised To Accelerate Commercialization Of Revi System | BlueWind Medical announced it has secured $47.8 million in financing through a combination of equity and debt to accelerate commercialization of its Revi System, an Implantable Tibial Neuromodulation (ITNM) therapy designed to treat urgency... |
| May 14, 2026 | Ouinex Raises $3.5M in Funding round; Total Reaches $9M | Ouinex, a Dubai, UAE-based developer of a digital asset and multi-asset derivative trading platform, raised $3.5m in an equity funding round, bringing its total community-funded capital to $9m. The round was backed entirely by a community o... |
| May 14, 2026 | BlueWind Medical Raises $47.8M in Equity and Debt | BlueWind Medical, a Salt Lake City, Utah-based developer of implantable tibial neuromodulation (ITNM) devices for urgency urinary incontinence, raised $47.8m in a combined equity and debt financing round. The round was backed by existing an... |
| May 9, 2022 | BlueWind Medical Raises $64M in Series B Funding | BluWind Medical, a Park City, UT- and Herzliya, Israel-based developer of the RENOVA iStim implantable tibial neuromodulation device, raised $64M in Series B funding. The round was led by ConvaTec. The company intends to use the funds to gr... |
| BlueWind Medical | “Revi™ is a minimally invasive, implantable tibial neuromodulation device that provides a transformative new therapy for urge urinary incontinence” |